The OCRL Gene Lowe oculocerebrorenal syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the OCRL gene, which are associated with Lowe syndrome. Lowe syndrome, also known as oculocerebrorenal syndrome, is a rare genetic disorder characterized by eye abnormalities, brain abnormalities, and kidney problems. This condition primarily affects males and can lead to a range of symptoms including cataracts, muscle weakness, intellectual disability, and renal impairment.
DNA Labs UAE provides this genetic testing service for individuals who may be at risk of having Lowe syndrome, or for families looking to understand their genetic health background. By analyzing the OCRL gene, this test can confirm a diagnosis of Lowe syndrome, assist in the management of the condition, and provide crucial information for family planning.
The cost of the OCRL Gene Lowe oculocerebrorenal syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect any mutations in the OCRL gene. Given the complexity of genetic testing and the specific expertise required to interpret the results, this test is a critical tool in the diagnosis and management of Lowe syndrome, offering patients and their families the information needed to navigate the condition with greater understanding and preparedness.
The XBP1 Gene Major Affective Disorder 7 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect genetic variations in the XBP1 gene that are associated with an increased risk of developing major affective disorders, including major depression and bipolar disorder. This test is particularly valuable for individuals with a family history of these conditions or those experiencing symptoms, as it can provide critical insights into their genetic predisposition. The process involves a simple DNA sample collection, typically through a blood draw or cheek swab, which is then analyzed for specific genetic markers linked to affective disorders.
The cost of the XBP1 Gene Major Affective Disorder 7 Genetic Test at DNA Labs UAE is 4400 AED. This investment in personal health allows individuals to gain a deeper understanding of their genetic makeup and its potential impact on their mental health. The results from this test can guide healthcare providers in developing more personalized and effective treatment plans, taking into account the genetic factors that may influence the course of the disorder. Additionally, it empowers individuals with actionable insights to make informed decisions about their mental health management and preventive strategies.
The CACNA1S gene is associated with a condition known as malignant hyperthermia type 5, a rare but severe reaction to certain anesthesia drugs, leading to a rapid increase in heart rate and body temperature, muscle rigidity, and other symptoms. This condition is genetic, meaning it is passed down through families.
To diagnose this condition and identify individuals at risk, a genetic test targeting the CACNA1S gene can be conducted. This test is crucial for people with a family history of malignant hyperthermia or those who have experienced symptoms of the condition during surgery. Early identification can help manage the risk and prepare safer anesthesia protocols for affected individuals.
In the United Arab Emirates, this specific genetic test is available at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the CACNA1S gene test for malignant hyperthermia type 5 at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals and healthcare providers to manage and mitigate the risks associated with malignant hyperthermia, ensuring safer surgical outcomes for those with the genetic predisposition.
TUBB4A Gene Leukodystrophy, Hypomyelinating Type 6, is a rare genetic disorder characterized by abnormalities in the development and maintenance of the myelin sheath, the protective covering of nerve cells. This condition leads to a range of neurological symptoms, including muscle stiffness, movement disorders, and developmental delays. The TUBB4A gene plays a crucial role in the proper formation of microtubules, essential components for cell structure and function, including in the nervous system.
To diagnose this condition, a genetic test targeting the TUBB4A gene can be conducted. DNA Labs UAE offers this specialized genetic test, designed to detect mutations in the TUBB4A gene that are responsible for Hypomyelinating Leukodystrophy Type 6. The test is a critical step for accurate diagnosis, allowing for a better understanding of the condition and facilitating tailored management and treatment plans for affected individuals.
The cost of the TUBB4A Gene Leukodystrophy hypomyelinating type 6 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the TUBB4A gene, providing essential information for affected families and their healthcare providers. By confirming a diagnosis through genetic testing, families can gain insights into the condition, its progression, and potential interventions to improve quality of life.
The POLR3A Gene Leukodystrophy Hypomyelinating Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the POLR3A gene, which are associated with Hypomyelinating Leukodystrophy Type 7 (HLD7). This condition is a rare genetic disorder characterized by the underdevelopment of the white matter in the brain, leading to a range of neurological symptoms such as delayed development, muscle stiffness, and difficulty coordinating movements. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect abnormalities in the POLR3A gene, providing crucial information for accurate diagnosis and potential treatment options. By identifying the genetic basis of the condition, healthcare providers can offer more personalized care plans and support for affected individuals and their families.
The POLR3B Gene Leukodystrophy hypomyelinating type 8 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the POLR3B gene, which are linked to a rare form of leukodystrophy known as hypomyelinating leukodystrophy type 8. This condition is characterized by a significant reduction in the white matter in the brain, which affects the myelin sheath, the material that surrounds and protects nerve fibers. As a result, individuals with this condition often experience a range of neurological symptoms, including motor and cognitive impairments.
The test is performed by DNA Labs UAE, a leading genetic testing facility in the United Arab Emirates known for its state-of-the-art technology and expertise in genetic diagnostics. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided by the lab. This test is crucial for families seeking answers about this genetic condition, as it not only confirms the diagnosis but also helps in understanding the disease progression, potential treatments, and management strategies. It is a vital tool in the field of personalized medicine, offering hope and support to affected individuals and their families.
The "RARS Gene Leukodystrophy Hypomyelinating Type 9 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RARS gene, which are associated with Hypomyelinating Leukodystrophy Type 9. This condition is a rare genetic disorder that affects the central nervous system, leading to a deficiency in myelin - the protective sheath that surrounds nerve fibers. Symptoms can include developmental delays, muscle stiffness, and difficulties with coordination and movement.
The test involves analyzing the patient's DNA to detect any abnormalities in the RARS gene, which plays a crucial role in protein synthesis necessary for myelin formation. Early detection through this genetic test can aid in the management and treatment planning for affected individuals, potentially improving their quality of life.
The cost of the RARS Gene Leukodystrophy Hypomyelinating Type 9 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its potential to provide critical insights into managing a rare neurological disorder, it represents a valuable investment in the health and well-being of individuals at risk for or suspected of having this condition.
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a rare genetic disorder caused by mutations in the DARS2 gene. This condition is characterized by changes in the white matter of the brain, specifically affecting the brainstem and spinal cord, and is often associated with elevated lactate levels, indicating a disruption in cellular energy production. Symptoms can include difficulties with movement and coordination, muscle stiffness, and developmental delays, among others.
To diagnose this condition, a genetic test targeting the DARS2 gene can be performed. This test involves analyzing the DNA to identify mutations in the DARS2 gene that are responsible for LBSL. It is a crucial step for confirming the diagnosis, understanding the disease's progression, and potentially guiding treatment options.
At DNA Labs UAE, this specialized genetic test for identifying DARS2 gene mutations associated with LBSL is available. The cost of the test is 4400 AED. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, providing essential information for patients and their families to manage the condition effectively.
The "SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the SCP2 gene, which are implicated in the development of leukoencephalopathy with dystonia and motor neuropathy. This condition is a rare neurological disorder characterized by changes in the brain's white matter, leading to dystonia (involuntary muscle contractions), motor neuropathy (nerve damage affecting muscle control), and a range of other neurological symptoms.
The test is crucial for individuals showing symptoms of the disorder or those with a family history, as it helps in confirming the diagnosis, understanding the progression of the disease, and planning appropriate management and treatment strategies. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the SCP2 gene.
At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify the genetic alterations associated with this complex condition. The results from this test can provide essential insights for affected individuals and their families, guiding clinical decisions and offering information on the genetic risk for future generations.
The EIF2B1 gene is associated with a rare neurological disorder known as Leukoencephalopathy with Vanishing White Matter (VWM). This condition is characterized by progressive deterioration of white matter in the brain, leading to symptoms such as motor dysfunction, spasticity, and in severe cases, premature death. The disorder is genetic in nature, inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are required for an individual to be affected.
A genetic test for mutations in the EIF2B1 gene can confirm a diagnosis of VWM, providing crucial information for affected individuals and their families regarding prognosis, potential treatments, and genetic counseling. The test involves analyzing DNA, usually from a blood sample, to identify mutations in the EIF2B1 gene that are known to cause the disorder.
In the UAE, DNA Labs offers this specialized genetic testing for individuals suspected of having Leukoencephalopathy with Vanishing White Matter. The cost of the test is 4400 AED, which reflects the sophisticated technology and expertise required to accurately identify mutations in the EIF2B1 gene. This test is a vital resource for families seeking answers about this rare and challenging condition, offering a path towards a more informed approach to care and management.
